Article
Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
The Lancet. Oncology - 1 Jun 2023
Huntley Catherine, Torr Bethany, Sud Amit, Rowlands Charlie F, Way Rosalind, Snape Katie, Hanson Helen, Swanton Charles, Broggio John, Lucassen Anneke, McCartney Margaret, Houlston Richard S, Hingorani Aroon D, Jones Michael E, Turnbull Clare
Abstract excerpt
BACKGROUND: It is proposed that, through restriction to individuals delineated as high risk, polygenic risk scores (PRSs) might enable more efficient targeting of existing cancer screening programmes and enable extension into new age ranges and disease types. To address this proposition, we present an overview of the performance of PRS tools (ie, models and sets of single nucleotide polymorphisms) alongside harms...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
